Navidea: Navidea Biopharmaceuticals files patent for polymeric compound for treating diseases involving macrophages
Discover how Navidea Biopharmaceuticals Inc. is revolutionizing targeted drug delivery with a patent for compounds to repolarize tumor-associated macrophages and treat cancer, autoimmune disorders, and infections.
Read full article »
CEO
- -Navidea is an Ohio-based biopharmaceutical company that researches and develops immunotherapeutics for the treatment of cancer, autoimmune, infectious, and inflammatory diseases.
Read more